Kerstin Papenfuss, PhD MBA

Kerstin Papenfuss, PhD MBA has over 12 years of experience in the field of biotechnology. In 2019, they began their current role as Associate Director, Therapeutics at Deep Science Ventures. Prior to this, they were Director at Antiverse (2020), University Liaison Manager at Cell and Gene Therapy Catapult (2018), Principal, Opportunity Assessment Group at LifeArc (2011) and Postdoctoral Research Associate & Research Associate at Imperial College London (2008). In 2007, they were a Research Associate at dkfz - German Cancer Research Center. At Imperial College London, their role included working within the field of tumour immunology on new cancer treatments, analysing molecular mechanisms, writing scientific manuscripts, articles and book chapters, and completing grant and patent applications.

Kerstin Papenfuss, PhD MBA has an educational background that includes a Bachelor of Science (B.Sc.) in Molecular Biotechnolgy from Universität zu Lübeck from 2001 to 2004, a Master of Science (MSc) in Molecular Life Science from Universität zu Lübeck from 2004 to 2006, and a Study Abroad at The University of Auckland in 2005. Kerstin then obtained a Doctor of Philosophy (Ph.D.) from Imperial College London from 2007 to 2010, and a Master of Business Administration (MBA) from Bayes Business School from 2017 to 2019. Additionally, they hold a Certificate of Attendance from the Institute for Competitive Intelligence.